Aquarius Surgical Technologies Inc. (CSE:ASTI)
Canada
· Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
At close: Dec 2, 2025
CSE:ASTI Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 0.07 | 0.09 | 0.21 | 0.2 | 0.33 | 0.58 | Upgrade
|
| Revenue | 0.07 | 0.09 | 0.21 | 0.2 | 0.33 | 0.58 | Upgrade
|
| Revenue Growth (YoY) | -57.16% | -55.56% | 0.74% | -37.82% | -43.84% | -39.15% | Upgrade
|
| Cost of Revenue | 0.03 | 0.04 | 0.07 | 0.12 | 0.2 | 0.37 | Upgrade
|
| Gross Profit | 0.04 | 0.05 | 0.13 | 0.08 | 0.13 | 0.22 | Upgrade
|
| Selling, General & Admin | 0.46 | 0.56 | 0.59 | 0.73 | 0.77 | 0.87 | Upgrade
|
| Amortization of Goodwill & Intangibles | 0.03 | 0.03 | 0.03 | 0.01 | 0.05 | 0.14 | Upgrade
|
| Operating Expenses | 0.49 | 0.59 | 0.62 | 0.73 | 0.82 | 1.01 | Upgrade
|
| Operating Income | -0.45 | -0.55 | -0.49 | -0.65 | -0.69 | -0.79 | Upgrade
|
| Interest Expense | -0.35 | -0.3 | -0.29 | -0.2 | -0.2 | -0.34 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.01 | -0.01 | 0.03 | -0.02 | -0.02 | -0.03 | Upgrade
|
| EBT Excluding Unusual Items | -0.81 | -0.86 | -0.75 | -0.86 | -0.89 | -1.15 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0 | -0.3 | 0 | 0.02 | 0.28 | - | Upgrade
|
| Asset Writedown | - | - | - | - | -0.25 | -0.68 | Upgrade
|
| Other Unusual Items | - | - | - | 0.12 | - | 0.02 | Upgrade
|
| Pretax Income | -0.81 | -1.17 | -0.75 | -0.72 | -0.86 | -1.81 | Upgrade
|
| Income Tax Expense | 0.01 | 0 | 0.01 | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -0.82 | -1.17 | -0.76 | -0.72 | -0.86 | -1.81 | Upgrade
|
| Net Income | -0.82 | -1.17 | -0.76 | -0.72 | -0.86 | -1.81 | Upgrade
|
| Net Income to Common | -0.82 | -1.17 | -0.76 | -0.72 | -0.86 | -1.81 | Upgrade
|
| Shares Outstanding (Basic) | 28 | 28 | 28 | 25 | 24 | 23 | Upgrade
|
| Shares Outstanding (Diluted) | 28 | 28 | 28 | 25 | 24 | 23 | Upgrade
|
| Shares Change (YoY) | - | - | 11.06% | 4.94% | 3.24% | 7.57% | Upgrade
|
| EPS (Basic) | -0.03 | -0.04 | -0.03 | -0.03 | -0.04 | -0.08 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.04 | -0.03 | -0.03 | -0.04 | -0.08 | Upgrade
|
| Free Cash Flow | -0.32 | -0.38 | -0.26 | 0.04 | -0.12 | -0.55 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | 0.00 | -0.01 | -0.02 | Upgrade
|
| Gross Margin | 53.72% | 51.87% | 64.73% | 40.21% | 39.77% | 37.12% | Upgrade
|
| Operating Margin | -688.71% | -598.19% | -238.54% | -319.89% | -209.79% | -135.88% | Upgrade
|
| Profit Margin | -1254.72% | -1279.85% | -369.14% | -355.09% | -262.22% | -310.30% | Upgrade
|
| Free Cash Flow Margin | -485.72% | -420.26% | -125.18% | 19.06% | -35.82% | -94.36% | Upgrade
|
| EBITDA | -0.44 | -0.54 | -0.49 | -0.65 | -0.64 | -0.66 | Upgrade
|
| EBITDA Margin | - | - | -236.53% | - | -194.20% | -112.64% | Upgrade
|
| D&A For EBITDA | 0.01 | 0 | 0 | 0 | 0.05 | 0.14 | Upgrade
|
| EBIT | -0.45 | -0.55 | -0.49 | -0.65 | -0.69 | -0.79 | Upgrade
|
| EBIT Margin | - | - | -238.54% | - | -209.79% | -135.88% | Upgrade
|
| Revenue as Reported | 0.07 | 0.09 | 0.21 | 0.2 | 0.33 | 0.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.